ITGAM and neoplasm: There were significantly fewer RMA-s tumor cells remained in CD11b−/− mice than that in WT mice, indicating that NK-dependent tumor cell killing is more efficient in CD11b−/− mice than that in WT mice (Figures 1B,C).